<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03372512</url>
  </required_header>
  <id_info>
    <org_study_id>BCM-CMR-T1</org_study_id>
    <nct_id>NCT03372512</nct_id>
  </id_info>
  <brief_title>Fluid Status and T1-mapping by CMR</brief_title>
  <acronym>BCM-CMR-T1</acronym>
  <official_title>Fluid Status Assessed by Bioelectrical Impedance Spectroscopy and Its Association With T1-mapping by Cardiovascular Magnetic Resonance Imaging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It is unclear to what extent systemic fluid overload has an impact on T1-mapping results by
      cardiovascular mangetic resonance imaging.

      In this study, patients will undergo body composition monitoring assessing systemic fluid
      overload and T1-mapping using MOLLI by cardiovacular magnetic resonance imaging in order to
      investigate a possible association with each other.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 15, 2017</start_date>
  <completion_date type="Anticipated">December 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 15, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>3 Years</target_duration>
  <primary_outcome>
    <measure>Native T1-mapping</measure>
    <time_frame>baseline</time_frame>
    <description>Association of fluid overload and native T1 values of left ventricular myocardium</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Extracellular Volume by Cardiovascular magnetic resonance imaging</measure>
    <time_frame>baseline</time_frame>
    <description>Association of fluid overload and extracellular volume of left ventricular myocardium</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Heart Diseases</condition>
  <condition>Heart Failure</condition>
  <condition>Valvular Heart Disease</condition>
  <arm_group>
    <arm_group_label>Fluid overload (Liters) ≥ median</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Fluid overload (Liters) &lt; median</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Bioimpedance spectroscopy</intervention_name>
    <description>Fluid overload will be assessed by bioimpedance spectroscopy</description>
    <arm_group_label>Fluid overload (Liters) ≥ median</arm_group_label>
    <arm_group_label>Fluid overload (Liters) &lt; median</arm_group_label>
    <other_name>BCM measurement</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing cardiovascular magnetic resonance imaging including T1-mapping are
        invited to participate in the study where fluid status will be assessed by bioimpedance
        spectroscopy right before cardiovascular magnetic resonance imaging.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  written informed consent

          -  patient undergoing cardiovascular magnetic resonance imaging

        Exclusion Criteria:

          -  Unwillingness to participate

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2017</study_first_submitted>
  <study_first_submitted_qc>December 12, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 13, 2017</study_first_posted>
  <last_update_submitted>December 12, 2017</last_update_submitted>
  <last_update_submitted_qc>December 12, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 13, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Dr. Andreas Kammerlander</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Valve Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

